| ASSET | QUARTER | % RETURN |
|---|---|---|
QXO (QXO) | Q2 2012 | 157,100% |
OLB (OLB) | Q2 2012 | 7,964.52% |
Vivakor (VIVK) | Q2 2012 | 842.42% |
Arena (AREN) | Q2 2012 | 448.38% |
Avita Medical (RCEL) | Q2 2012 | 369.77% |
Supercom (SPCB) | Q2 2012 | 275% |
Clearpoint Neuro (CLPT) | Q2 2012 | 206.67% |
Live Ventures (LIVE) | Q2 2012 | 191% |
Nova Lifestyle I (NVFY) | Q2 2012 | 163.2% |
B Riley Financial (RILY) | Q2 2012 | 135.72% |
Oragenics (OGEN) | Q2 2012 | 122.73% |
Good Times Restaurants (GTIM) | Q2 2012 | 116.67% |
PEDEVCO (PED) | Q2 2012 | 108.33% |
Turtle Beach (TBCH) | Q2 2012 | 104.69% |
Perspective Therapeutics (CATX) | Q2 2012 | 102% |
Aware (AWRE) | Q2 2012 | 101.51% |
TROOPS (TROO) | Q2 2012 | 100% |
XWELL (XWEL) | Q2 2012 | 98.97% |
Mannatech (MTEX) | Q2 2012 | 96.9% |
Heron Therapeuti (HRTX) | Q2 2012 | 95.71% |
Air Industries (AIRI) | Q2 2012 | 94.72% |
Nephros (NEPH) | Q2 2012 | 92.31% |
MiMedx (MDXG) | Q2 2012 | 77.97% |
Cocrystal Pharma (COCP) | Q2 2012 | 77.78% |
ProMIS Neurosciences (PMN) | Q2 2012 | 77.78% |
